Wednesday, March 19, 2008

Alaska, Zyprexa, $3 Billion?

Bloomberg.com opens with the following.

"March 18 (Bloomberg) -- An adverse jury decision in Alaska may be the first step in tripling to more than $3 billion Eli Lilly & Co.'s costs of resolving lawsuits over Zyprexa, which generates more than one-fourth of the company's revenue."

It seems Eli Lilly was remiss in warning of Diabetes risk related to its Zyprexa.

3 Billion dollars? Can you imagine what $3 Billion - even in neat stacks of brand new banded $100 bills would look like?


If you scroll down the page right here, two posts ago, you'll have no trouble imagining what tardive dyskinesia looks like.

No comments: